MAI Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.5M Buy
100,869
+13,589
+16% +$4.65M 0.14% 143
2026
Q1
$30.7M Buy
87,280
+856
+1% +$305K 0.17% 116
2025
Q4
$28.3M Buy
86,424
+9,133
+12% +$2.9M 0.16% 127
2025
Q3
$21.8M Buy
77,291
+6,660
+9% +$1.93M 0.14% 144
2025
Q2
$19.7M Sell
70,631
-767
-1% -$217K 0.14% 140
2025
Q1
$22.2M Buy
71,398
+372
+0.5% +$110K 0.17% 123
2024
Q4
$18.5M Buy
71,026
+31,595
+80% +$9.37M 0.14% 135
2024
Q3
$12.7M Sell
39,431
-5,862
-13% -$1.92M 0.12% 133
2024
Q2
$14.2M Sell
45,293
-481
-1% -$141K 0.14% 119
2024
Q1
$13M Buy
45,774
+6,933
+18% +$2.03M 0.13% 127
2023
Q4
$11.2M Buy
38,841
+19
+0% +$5.18K 0.15% 128
2023
Q3
$10.4M Buy
38,822
+559
+1% +$140K 0.16% 125
2023
Q2
$8.5M Sell
38,263
-1,131
-3% -$262K 0.13% 145
2023
Q1
$9.52M Sell
39,394
-1,843
-4% -$452K 0.15% 129
2022
Q4
$10.8M Sell
41,237
-484
-1% -$130K 0.18% 117
2022
Q3
$9.4M Buy
41,721
+9,496
+29% +$2.3M 0.18% 120
2022
Q2
$7.84M Sell
32,225
-1,246
-4% -$305K 0.15% 126
2022
Q1
$8.09M Sell
33,471
-1,461
-4% -$336K 0.14% 131
2021
Q4
$7.86M Sell
34,932
-38,571
-52% -$8.14M 0.13% 137
2021
Q3
$15.6M Buy
73,503
+3,153
+4% +$726K 0.3% 84
2021
Q2
$17.1M Buy
70,350
+28
+0% +$6.89K 0.34% 78
2021
Q1
$17.5M Sell
70,322
-12,562
-15% -$3M 0.39% 66
2020
Q4
$19.1M Buy
82,884
+1,688
+2% +$389K 0.48% 52
2020
Q3
$20.6M Sell
81,196
-135
-0.2% -$33.4K 0.6% 43
2020
Q2
$19.2M Buy
81,331
+1,920
+2% +$438K 0.6% 45
2020
Q1
$16.1M Buy
79,411
+2,931
+4% +$640K 0.66% 40
2019
Q4
$18.4M Buy
76,480
+869
+1% +$192K 0.6% 45
2019
Q3
$14.6M Sell
75,611
-2,413
-3% -$463K 0.65% 40
2019
Q2
$14.4M Buy
78,024
+76
+0.1% +$13.6K 0.65% 38
2019
Q1
$14.8M Buy
77,948
+1,446
+2% +$276K 0.76% 34
2018
Q4
$14.9M Buy
76,502
+4,057
+6% +$791K 0.87% 31
2018
Q3
$15M Sell
72,445
-534
-0.7% -$105K 0.77% 29
2018
Q2
$13.5M Buy
72,979
+1,514
+2% +$268K 0.73% 28
2018
Q1
$12.2M Buy
71,465
+735
+1% +$135K 0.69% 33
2017
Q4
$12.3M Sell
70,730
-3,193
-4% -$565K 0.7% 37
2017
Q3
$13.8M Buy
73,923
+191
+0.3% +$33.8K 0.84% 27
2017
Q2
$12.7M Buy
73,732
+694
+1% +$113K 0.82% 27
2017
Q1
$12M Sell
73,038
-2,079
-3% -$345K 0.81% 30
2016
Q4
$11M Buy
75,117
+6,308
+9% +$949K 0.8% 31
2016
Q3
$11.5M Sell
68,809
-5,516
-7% -$933K 0.87% 32
2016
Q2
$11.3M Sell
74,325
-8,810
-11% -$1.37M 0.87% 33
2016
Q1
$12.5M Buy
83,135
+114
+0.1% +$16.9K 0.95% 28
2015
Q4
$13.5M Sell
83,021
-2,380
-3% -$374K 1.03% 24
2015
Q3
$11.8M Buy
85,401
+2,114
+3% +$333K 0.89% 32
2015
Q2
$12.8M Buy
83,287
+903
+1% +$145K 0.84% 29
2015
Q1
$13.2M Buy
82,384
+19,360
+31% +$3.05M 0.88% 27
2014
Q4
$10M Buy
63,024
+1,860
+3% +$290K 0.7% 46
2014
Q3
$8.59M Buy
61,164
+1,100
+2% +$144K 0.83% 39
2014
Q2
$7.11M Buy
60,064
+56,022
+1,386% +$6.49M 0.68% 48
2014
Q1
$499K Hold
4,042
0.05% 231
2013
Q4
$461K Hold
4,042
0.05% 236
2013
Q3
$452K Buy
4,042
+500
+14% +$54.2K 0.06% 206
2013
Q2
$349K Buy
+3,542
New +$368K 0.05% 224

Other funds holding AMGN

MAI Capital Management's AMGN Position: Q2 2026 in Review

MAI Capital Management increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $4.65M and bringing the position to 100,869 shares worth $36.5M. The position accounts for 0.14% of the portfolio, ranked #143.

MAI Capital Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MAI Capital Management held 100,869 shares of Amgen worth $36.5M as of Q2 2026.
  • MAI Capital Management bought 13,589 Amgen shares in Q2 2026, an estimated $4.65M.
  • Amgen made up 0.14% of MAI Capital Management's portfolio in Q2 2026, its #143 holding.
  • MAI Capital Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.